CASE REPORT article
Front. Oncol.
Sec. Genitourinary Oncology
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1542368
Diagnosis and therapy of recurrent renal metastases after surgery for testicular seminoma: a rare case report and review of the literature
Provisionally accepted- 1Department of Urology, Guizhou Provincial People's Hospital, Guiyang, Guizhou Province, China
- 2Department of Urology, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou Province, China
- 3School of Medicine, Guizhou University, Guiyang, Guizhou Province, China
- 4Department of Urology, Second Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou Province, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Seminoma is a malignant tumor arising from testicular germ cells, with cryptorchidism recognized as a major risk factor for its development. Although retroperitoneal lymph node metastasis is common, renal metastasis is exceedingly rare. Testicular seminomas are generally highly sensitive to chemotherapy; however, the treatment and prognosis become significantly more challenging in cases of distant metastasis.Case presentation: This case report describes a 39-year-old male patient who unexpectedly discovered a left testicular seminoma following surgery but did not receive postoperative adjuvant chemotherapy due to personal reasons. Thirteen months after surgery, the patient was admitted for left-sided lumbar pain for 1 month. Abdominal enhanced CT imaging revealed a large renal tumor measuring 115×120 ×97 mm at the lower pole of the left kidney. The patient subsequently underwent a percutaneous biopsy of the left renal mass, and histopathological examination confirmed that the renal tumor originated from testicular seminoma. The patient then received four cycles of BEP (bleomycin, etoposide, and cisplatin) chemotherapy. Follow-up abdominal CT showed a reduction in the size of the left renal tumor to 56 ×45×60 mm, with several enlarged lymph nodes in the abdominal cavity and retroperitoneum (the largest approximately 10 mm in diameter). The patient eventually underwent "left nephrectomy and partial retroperitoneal lymph node dissection". Postoperative histopathological analysis revealed no evidence of residual tumor cells. Shortly after surgery, the patient developed acute complete intestinal obstruction, which was treated surgically, and his condition improved significantly. The patient maintained clinical stability throughout the 4-month followup period without evidence of disease recurrence. Conclusion: Postoperative adjuvant chemotherapy is essential for patients with testicular seminoma to minimize the risk of tumor recurrence and metastasis. In cases of renal metastasis from seminoma, salvage chemotherapy using the BEP regimen combined with nephrectomy may contribute to improved clinical outcomes.
Keywords: Seminoma, renal metastatic tumor, Cryptorchidism, chemotherapy, Nephrectomy
Received: 09 Dec 2024; Accepted: 22 Apr 2025.
Copyright: © 2025 Li, Luo, Yu, Su, Yuan and Zhu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Jianguo Zhu, Department of Urology, Guizhou Provincial People's Hospital, Guiyang, 550002, Guizhou Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.